Suchergebnisse - "Kim, Seung Joon"

PubPharm (260)

1

Real-world outcome of crizotinib for anaplastic lymphoma kinase-positive lung cancer : Multicenter retrospective analysis in South Korea

enthalten in: Thoracic cancer | 2024

von Jeon, D. | Park, C. | Kim, S. | +15

2

Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer

enthalten in: Cancers | 2024

von Kim, H. | Lee, J. | Oh, I. | +11

3

Correction : Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC)

enthalten in: Journal of experimental & clinical cancer research : CR | 2023

von Lee, S. | Cho, H. | Choi, J. | +20

ErratumFor: J Exp Clin Cancer Res. 2023 Nov 22;42(1):309. - PMID 37993887

4

Correction: Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC)

enthalten in: Journal of experimental & clinical cancer research | 2023

von Lee, S. | Cho, H. | Choi, J. | +20

5

Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea : updated survival data

enthalten in: Translational lung cancer research | 2023

von Choi, J. | Choi, C. | Chang, Y. | +14

6

Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC)

enthalten in: Journal of experimental & clinical cancer research : CR | 2023

von Lee, S. | Cho, H. | Choi, J. | +20

ErratumIn: J Exp Clin Cancer Res. 2023 Dec 6;42(1):332. - PMID 38057916

7

Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC)

enthalten in: Journal of experimental & clinical cancer research | 2023

von Lee, S. | Cho, H. | Choi, J. | +20

8

Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non-Small Cell Lung Cancer : Updated Analysis of the RESET Study

enthalten in: Cancer research and treatment | 2023

von Kim, T. | Jang, T. | Choi, C. | +14

9

Identification of predictive factors for early relapse in patients with unresectable stage III non-small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation therapy

enthalten in: Thoracic cancer | 2023

von Nam, J. | Yeo, C. | Park, C. | +7

10

Prediction of Postoperative Lung Function in Lung Cancer Patients Using Machine Learning Models

enthalten in: Tuberculosis and respiratory diseases | 2023

von Kwon, O. | Han, S. | Lee, H. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[26]